Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.4B | 7.7B | 6.8B | 5.8B |
Cost of revenue | 3.7B | 3.8B | 3.4B | 3.0B |
Gross profit | 3.7B | 3.9B | 3.4B | 2.9B |
Operating expense | ||||
Research & development | 1.7B | 1.7B | 1.6B | 1.6B |
Selling general and admin | 886M | 792M | 721M | 650M |
Other operating expenses | — | -11M | -14M | -10M |
Operating income | 806M | 1.1B | 724M | 269M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 20M | 19M | 23M | 25M |
Other income expense | 39M | -331M | 36M | 55M |
Pretax income | 825M | 889M | 737M | 299M |
Tax provision | 123M | 419M | -27M | 41M |
Net income | 709M | 482M | 771M | 265M |
Basic EPS | 0.4 | 0.3 | 0.5 | 0.2 |
Diluted EPS | 0.4 | 0.3 | 0.5 | 0.2 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 1.6B | 1.7B | 1.5B | 1.1B |
Net income from continuing op. | 709M | 482M | 771M | 265M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |